NCT07901699Active, not recruiting
Resumption of Anticoagulation After Major Gastrointestinal Bleeding in Patients With Atrial Fibrillation
Source: ClinicalTrials.gov · Last updated 2 Nov 2026
Brief summary (registry, in English)
Prospective multicenter observational study on resumption of anticoagulant therapy after major gastrointestinal bleeding in patients with atrial fibrillation
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 650 (estimated)
- First submitted
- 22 Oct 2026
- Start date
- 5 Jan 2024
- Primary completion date
- 30 Nov 2026
- Lead sponsor
- Società Italiana di Medicina Interna
- Diseases
- Atrial fibrillation
- NCT number
- NCT07901699
What you commit to
- Study type: Observational
- Planned participants: 650
- From 5 Jan 2024 to the primary completion date, 30 Nov 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Any condition deemed by the physician to endanger patient safety in case of inclusion in the study
Other
- Indication for anticoagulant treatment is different from atrial fibrillation
- Refusal of informed consent
Who the study is looking for
- Adults ≥ 18 years old
- confirmed atrial fibrillation on treatment with VKAs or DOACs;
- Signed informed consent;
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Azienda Ospedaliera di Perugia Coordinator of this site? Confirm its status | Perugia | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.